(PRESS RELEASE) FRANKFURT, 14-Jan-2020 — /EuropaWire/ — The Medical Cannabis and Wellness UCITS ETF, developed by HANetf and leading Canada-based asset manager Purpose Investment Inc., is a new Exchange Traded Fund (ETF) that is going to be tradable on Xetra and Börse Frankfurt via the white label platform of HANetf starting from 14 January 2020.
Purpose Investment Inc.’s ETF is both first in Europe to focus on companies primarily active in the medical cannabis, hemp and cannabidiol (CBD) industry and the company’s first ETF to be listed via HANetf white label platform.
At this moment, 13 companies active in the production of medical cannabis and related products and services will be part of the benchmark index. Products from medical cannabis and cannabidiol are often used to to treat diseases such as cancer, epilepsy and chronic pain. The index is weighted according to market capitalisation, with a maximum of 10% of a company’s share in the quarterly rebalancing.
Name: HANetf The Medical Cannabis and Wellness UCITS ETF – Acc
Asset class: Equity ETF
Ongoing charges: 0.80 per cent
Distribution policy: Accumulating
Reference index: Medical Cannabis and Wellness Equity Index
Ireland domiciled The Medical Cannabis and Wellness UCITS ETF is a UCITS compliant Exchange Traded Fund. The Fund tracks an index designed to measure the performance of an investable pool of publicly listed companies with significant business activities in the medical cannabis, hemp and CBD industry.
More information can be found at: https://www.hanetf.com/product/6/fund/the-medical-cannabis-and-wellness-ucits-etf-acc
There are currently in 1,507 ETFs in Deutsche Börse’s XTF segment offering boosting a monthly trading volume of around €11 billion making Xetra the leading trading venue for ETFs in Europe.
+49-(0) 69-2 11-1 15 01
SOURCE: Deutsche Börse